135 related articles for article (PubMed ID: 38478955)
1. Non-small cell lung carcinoma with focal coexpression of thyroid transcription factor-1 and Δ Np63/p40: A case report.
Terada K; Menju T; Date H; Haga H; Yoshizawa A
Thorac Cancer; 2024 Apr; 15(12):1029-1033. PubMed ID: 38478955
[TBL] [Abstract][Full Text] [Related]
2. Non-small cell lung carcinoma with diffuse coexpression of thyroid transcription factor-1 and ΔNp63/p40.
Hayashi T; Takamochi K; Yanai Y; Mitani K; Tomita H; Mogushi K; Suehara Y; Takahashi F; Suzuki K; Saito T; Yao T
Hum Pathol; 2018 Aug; 78():177-181. PubMed ID: 29410129
[TBL] [Abstract][Full Text] [Related]
3. Napsin A/p40 antibody cocktail for subtyping non-small cell lung carcinoma on cytology and small biopsy specimens.
Nishino M; Hoang MP; Della Pelle P; Morales-Oyarvide V; Huynh TG; Mark EJ; Mino-Kenudson M
Cancer Cytopathol; 2016 Jul; 124(7):472-84. PubMed ID: 27412420
[TBL] [Abstract][Full Text] [Related]
4. Utility of a novel triple marker (combination of thyroid transcription factor 1, Napsin A, and P40) in the subclassification of non-small cell lung carcinomas using fine-needle aspiration cases.
Sharma R; Wang Y; Chen L; Gurda GT; Geddes S; Gabrielson E; Askin F; Li QK
Hum Pathol; 2016 Aug; 54():8-16. PubMed ID: 27045515
[TBL] [Abstract][Full Text] [Related]
5. The Value of Cytokeratin 5/6, p63 and Thyroid Transcription Factor-1 in Adenocarcinoma, Squamous Cell Carcinoma and Non-Small-Cell Lung Cancer of the Lung.
Argon A; Nart D; Veral A
Turk Patoloji Derg; 2015; 31(2):81-8. PubMed ID: 25944390
[TBL] [Abstract][Full Text] [Related]
6. p40 & thyroid transcription factor-1 immunohistochemistry: A useful panel to characterize non-small cell lung carcinoma-not otherwise specified (NSCLC-NOS) category.
Walia R; Jain D; Madan K; Sharma MC; Mathur SR; Mohan A; Iyer VK; Kumar L
Indian J Med Res; 2017 Jul; 146(1):42-48. PubMed ID: 29168459
[TBL] [Abstract][Full Text] [Related]
7. Various Antibody Clones of Napsin A, Thyroid Transcription Factor 1, and p40 and Comparisons With Cytokeratin 5 and p63 in Histopathologic Diagnostics of Non-Small Cell Lung Carcinoma.
Tran L; Mattsson JS; Nodin B; Jönsson P; Planck M; Jirström K; Botling J; Micke P; Brunnström H
Appl Immunohistochem Mol Morphol; 2016 Oct; 24(9):648-659. PubMed ID: 26447895
[TBL] [Abstract][Full Text] [Related]
8. Immunoreactivity for thyroid transcription factor-1 in stage I non-small cell carcinomas of the lung.
Pelosi G; Fraggetta F; Pasini F; Maisonneuve P; Sonzogni A; Iannucci A; Terzi A; Bresaola E; Valduga F; Lupo C; Viale G
Am J Surg Pathol; 2001 Mar; 25(3):363-72. PubMed ID: 11224607
[TBL] [Abstract][Full Text] [Related]
9. ΔNp63, CK5/6, TTF-1 and napsin A, a reliable panel to subtype non-small cell lung cancer in biopsy specimens.
Zhao W; Wang H; Peng Y; Tian B; Peng L; Zhang DC
Int J Clin Exp Pathol; 2014; 7(7):4247-53. PubMed ID: 25120805
[TBL] [Abstract][Full Text] [Related]
10. Thyroid-like low-grade nasopharyngeal papillary adenocarcinoma with squamous differentiation: a novel histological finding.
Oide T; Kadosono O; Matsushima J; Wu D; Nagashima H; Saigusa H; Masunaga A; Nakatani Y; Hiroshima K
Hum Pathol; 2017 Dec; 70():43-48. PubMed ID: 28601658
[TBL] [Abstract][Full Text] [Related]
11. Reevaluation and reclassification of resected lung carcinomas originally diagnosed as squamous cell carcinoma using immunohistochemical analysis.
Kadota K; Nitadori J; Rekhtman N; Jones DR; Adusumilli PS; Travis WD
Am J Surg Pathol; 2015 Sep; 39(9):1170-80. PubMed ID: 25871623
[TBL] [Abstract][Full Text] [Related]
12. Non-small cell lung carcinomas with diffuse coexpression of TTF1 and p40: clinicopathological and genomic features of 14 rare biphenotypic tumours.
Savari O; Febres-Aldana C; Chang JC; Fanaroff RE; Ventura K; Bodd F; Paik P; Vundavalli M; Saqi A; Askin FB; Travis WD; Rekhtman N
Histopathology; 2023 Jan; 82(2):242-253. PubMed ID: 36130728
[TBL] [Abstract][Full Text] [Related]
13. A study of ΔNp63 expression in lung non-small cell carcinomas.
Nonaka D
Am J Surg Pathol; 2012 Jun; 36(6):895-9. PubMed ID: 22367298
[TBL] [Abstract][Full Text] [Related]
14. Agreement of CK5/6, p40, and p63 immunoreactivity in non-small cell lung cancer.
Kriegsmann K; Cremer M; Zgorzelski C; Harms A; Muley T; Winter H; Kazdal D; Warth A; Kriegsmann M
Pathology; 2019 Apr; 51(3):240-245. PubMed ID: 30798982
[TBL] [Abstract][Full Text] [Related]
15. ΔNp63 (p40) and thyroid transcription factor-1 immunoreactivity on small biopsies or cellblocks for typing non-small cell lung cancer: a novel two-hit, sparing-material approach.
Pelosi G; Fabbri A; Bianchi F; Maisonneuve P; Rossi G; Barbareschi M; Graziano P; Cavazza A; Rekhtman N; Pastorino U; Scanagatta P; Papotti M
J Thorac Oncol; 2012 Feb; 7(2):281-90. PubMed ID: 22071786
[TBL] [Abstract][Full Text] [Related]
16. TP53, NOTCH2, and STK11 Mutations in a Rare Tumor of non-Small Cell Lung Carcinoma with Diffuse Coexpression of TTF1 and p40 in the Same Tumor Cells.
Guo X; Dong L; Liu H; Chen X
Int J Surg Pathol; 2023 Sep; 31(6):1041-1047. PubMed ID: 36253711
[No Abstract] [Full Text] [Related]
17. ΔNp63 (p40) distribution inside lung cancer: a driver biomarker approach to tumor characterization.
Pelosi G; Rossi G; Cavazza A; Righi L; Maisonneuve P; Barbareschi M; Graziano P; Pastorino U; Garassino M; de Braud F; Papotti M
Int J Surg Pathol; 2013 Jun; 21(3):229-39. PubMed ID: 23486764
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical staining for thyroid transcription factor-1: a helpful aid in discerning primary site of tumor origin in patients with brain metastases.
Srodon M; Westra WH
Hum Pathol; 2002 Jun; 33(6):642-5. PubMed ID: 12152164
[TBL] [Abstract][Full Text] [Related]
19. Use of thyroid transcription factor 1, PE-10, and cytokeratins 7 and 20 in discriminating between primary lung carcinomas and metastatic lesions in fine-needle aspiration biopsy specimens.
Chhieng DC; Cangiarella JF; Zakowski MF; Goswami S; Cohen JM; Yee HT
Cancer; 2001 Oct; 93(5):330-6. PubMed ID: 11668468
[TBL] [Abstract][Full Text] [Related]
20. [Quantitative study of thyroid transcription factor-1 protein expression in lung carcinoma cell nucleus by tissue microarray].
Bai XY; Shen H
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Oct; 26(10):1423-6. PubMed ID: 17062341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
